Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-05-14-Speech-2-034"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20020514.4.2-034"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Mr President, I wish to thank Mr Caudron and Commissioner Busquin for their hard work in difficult circumstances. In particular, I welcome the funding for sustainability and renewable energy in this programme.
With regard to ethical dilemmas in biotechnology, we need to take these, and the efforts to respond to ethical concerns in funding EU research very seriously. In particular: the patenting of the human genome; human cloning in its various forms; the manipulation and modification of the human germ line – which is a particular concern – and the
and use of human embryos in research. Our citizens are very concerned and our policies and funding should match their concerns.
I have some animal welfare concerns also, in particular developing validation of alternative methods for animal testing and hastening the replacement of animal-based toxicity testing with regard to chemicals policy.
With regard to funding for health, I have welcomed the modifications here and would thank Mr Caudron for his concern, because human genome research cannot be the only strand of health research funded by the EU. It looked as if that might happen, so I welcome the funding for health and complementary medicine.
Finally, I know that the Euratom programme is not part of the EC programme and is not subject to codecision, but I would welcome an assurance from the Commissioner that the Commission will reflect European Parliament concerns in its activities, and in particular our amendments to the Euratom programme."@en1
|
| lpv:spokenAs | |
| lpv:unclassifiedMetadata |
"creation"1
|
Named graphs describing this resource:
The resource appears as object in 2 triples